Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. - Wikidata - awgldk - TriplyDB

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.

http://www.wikidata.org/entity/Q34808562

about

Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons.The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.Gene expression patterns associated with neurological disease in human HIV infection Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals HIV-1 neuroimmunity in the era of antiretroviral therapy.Pathogenesis of HIV in the central nervous system HIV protease inhibitor exposure predicts cerebral small vessel disease.Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature.Mechanisms of HIV-tat-induced phosphorylation of N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for neuroAIDS pathogenesis Glutamate metabolism and HIV-associated neurocognitive disorders.Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.HIV-associated neurocognitive disorder.Host genetic factors predisposing to HIV-associated neurocognitive disorder.PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders.A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.Impact of antiretroviral therapy on HIV-related brain injury.Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field.Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection.Factors related to HIV-associated neurocognitive impairment differ with age.Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.Editorial neuroAIDS review.Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND).HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals

P2860

Q26800052-6E75CD1B-0227-4430-AE88-363470193AEB Q26859071-66A6ADAA-70A4-47FC-9F5C-849544E4F690 Q26865707-6A2CBF63-1002-473B-87DA-91CB2DDAF66C Q28645981-EBB2B850-AFD8-4E49-AE23-45EE6F05D60A Q28709047-8079F57D-0A6E-4A8E-AA29-8A314FEB91FD Q30234305-977F0B6A-A1AD-41B3-9C65-D78FBF891250 Q30738175-380E14B0-124F-4AE6-A806-899BD0BA99E3 Q31104394-6FD41B0B-51E8-4F52-AE05-0A17A86E842C Q33605737-172479C4-D9C5-4054-998A-C912DA477AB4 Q33614467-A70B83F3-B206-408B-8616-FFD80300BE9A Q33733529-1589E41B-494D-4CD1-AFE2-300B3523C25F Q33781978-5F567AA3-DC6D-4319-973C-5DDD58277132 Q33807507-D434BED4-4B14-4DDF-A6BA-93F44C37CD3C Q33863368-21873399-308A-4EED-B938-3280D8329207 Q33879231-BBAB8650-2B74-4853-95D7-51CC4F194FBB Q33882476-C5E64539-AAFE-431A-ACEE-565766FD4C06 Q33903612-EF00D3A6-563D-44B1-AD5F-F1215815CEA7 Q33936233-657E7989-9CB0-41B9-96EB-4D9509503840 Q33939729-91D0FE05-6105-41DC-A076-87DA4FD6BD22 Q34001122-D7687204-266B-4CB4-8F23-6DAFAD1C3131 Q34162407-73E79D42-0412-4CA7-8DB7-B1DE044D2391 Q34248380-28157FA6-9A8D-410D-96FC-6E8BDE00C334 Q34376412-76C0D42F-91A8-45C8-8144-4A9785E1CFD9 Q34482480-44EA57A8-B96A-4BA6-88F3-7CB54B915584 Q34699119-4F905B6D-5A81-4C9C-80F3-BECF61010DD0 Q34988471-439B44DD-96F7-409A-8F41-017FBA7A7A48 Q35000836-42DB440B-D9E9-4987-82FA-290F89A21916 Q35058626-A142C07A-B477-45B5-9503-3743069DAAF3 Q35125996-402B891B-FECB-4DB4-8FD0-C06C4B14A31C Q35154529-5506655D-C3EE-4334-82F3-45B5499627C1 Q35266342-CCAF8903-4923-45AD-A7DE-96A90242918C Q35276630-C7A574B1-3B72-4216-936B-D4C2A754D6AC Q35532868-BAAB4BAA-807E-4E95-ACC5-E2B1689DD8CB Q35562611-9BE1B79E-22DA-4E05-878A-8359CDB4900D Q35731648-91C73780-8AEA-4094-A095-511D4EB6935A Q35787684-DB1667A7-E8A7-4F67-B5B9-4DD6D4A6C78B Q35850857-7BAD3D7E-1FD3-40A7-AABD-1A8D8CA00043 Q35856810-9DA2A356-3A9E-40DC-88A4-77AB66B7A759 Q35895155-66778978-2960-4E6F-9984-CB063E840C4D Q35902953-45340102-F626-40F2-9DA4-1B67C497A26E

P2860

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.

http://www.wikidata.org/entity/Q34808562

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@ast

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@en

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@nl

type

label

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@ast

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@en

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@nl

prefLabel

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@ast

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@en

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@nl

P1433

Q34808562-A8C2B33A-8DE9-45C4-BC0B-639CAA7400A3

P1476

Q34808562-7CC0B55D-CB64-4D7D-9815-474022D7BD04

P2093

Q34808562-4E5250B6-778D-4B43-A694-C1721F0C3926

Q34808562-676760EB-6EFD-485E-BE04-E50A29A31856

Q34808562-6F96C223-853C-4BA5-8A8D-92B8C85E0EA8

Q34808562-821442DE-97C3-4E20-9827-AFD89BBCE36A

Q34808562-822CCD27-B637-44EA-86DB-0310426695D1

Q34808562-99628F1E-771C-4097-AFDE-2164BCA81E5F

Q34808562-B49B8A67-C3AF-4F41-84D9-81C01C2FB988

Q34808562-B56E9BCF-1235-4473-A813-321FE1241AE0

Q34808562-BA170DC0-4429-4F4D-8BDD-F0188A4958B4

Q34808562-BAD9BBEF-8548-44FD-AB97-7735AE48E86F

P2860

Q34808562-012887C0-9D85-490E-9FFF-A1E8D360B3A6

Q34808562-01F434F3-3273-4C66-A53B-FB503C4E3ED5

Q34808562-04FA60CC-A461-4C81-B110-477FFCF56C60

Q34808562-066EDA13-3E65-41D8-9706-79D2AE3B31BF

Q34808562-09603405-A72E-4AAA-931B-E55767499578

Q34808562-111A0A17-2C90-4E2D-A5AD-962EF58E7E1B

Q34808562-2210935E-D971-4F24-8109-66A7C409B721

Q34808562-32EEA2F3-4480-4A18-9963-47B678159A4D

Q34808562-35828028-F50D-42CB-8E01-191DC20D7343

Q34808562-3E0E9D76-7961-4063-B641-6CBE7E2F55EC

P2888

Q34808562-E9F99AF4-BE02-4695-B6A2-8EF15085608C

P304

Q34808562-3576609F-355C-4A1D-B8B2-50988243EA99

P31

Q34808562-2BAA9BF9-6834-41E6-A8CF-3B6179C70B65

P356

Q34808562-3CE124B9-E8CB-465D-B9B7-C543A25DEC89

P433

Q34808562-DD6B7F06-AAC8-4FB9-83DB-F150CD9790BD

P478

Q34808562-C566AB6C-3D18-4CD9-B6FB-9EEBCD76651F

P50

Q34808562-B37B7BE2-B151-4B87-892D-7D349BBFDED6

P577

Q34808562-783DFCE3-1DCF-4FFC-8199-C4F38E63A969

P5875

Q34808562-8FAC7CF0-1348-46C5-A0CC-3484ACC556B4

P6179

Q34808562-528EF6DF-80BC-433E-B0AF-968CCB3C2341

P698

Q34808562-297CBE5A-476E-4F14-B403-222F1B0C1401

P921

Q34808562-852D6535-423E-45C3-B7DA-544241B07785

P932

Q34808562-96BDD91D-5A8B-4C78-92B6-B5D3E6DDD672

P356

13550280903131915

P1433

Journal of NeuroVirology

P1476

Cliniconeuropathologic correla ...... era of antiretroviral therapy.

@en

P2093

B Gelman

http://www.w3.org/2001/XMLSchema#string

C Achim

http://www.w3.org/2001/XMLSchema#string

D Lazzaretto

http://www.w3.org/2001/XMLSchema#string

D Moore

http://www.w3.org/2001/XMLSchema#string

E Masliah

http://www.w3.org/2001/XMLSchema#string

E Singer

http://www.w3.org/2001/XMLSchema#string

F Vaida

http://www.w3.org/2001/XMLSchema#string

I Everall

http://www.w3.org/2001/XMLSchema#string

I Grant

http://www.w3.org/2001/XMLSchema#string

M Cherner

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-HIV drug distribution to the central nervous system.

Dementia and neurocognitive disorders due to HIV-1 infection.

Antiretroviral therapy regimens for neuro-AIDS.

Changing patterns in the neuropathogenesis of HIV during the HAART era.

An update on the neuropathology of HIV in the HAART era.

HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.

Neuropathology of human immunodeficiency virus infection.

Antiretroviral therapy and central nervous system HIV type 1 infection

The Neuropathology of HIV/AIDS.

Neurocognitive disturbances in HIV.

P2888

13550280903131915

P304

360-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13550280903131915

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41531182

http://www.w3.org/2001/XMLSchema#string

P6179

1004496397

http://www.w3.org/2001/XMLSchema#string

P698

20175693

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3078805

http://www.w3.org/2001/XMLSchema#string